739
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors

, MD, , MD, , MD, , MD, , MD, , MD, MPH, , MD, , MD & , MD, MPH show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Katharine F. Marshall, Patricia A. Carney, Kathryn J. Bonuck, Patricio Riquelme & Jonathan Robbins. (2023) Preparing fourth year medical students to care for patients with opioid use disorder: how this training affects their intention to seek addiction care opportunities during residency. Medical Education Online 28:1.
Read now
Emma Gugala, Owanate Briggs, Leticia R. Moczygemba, Carolyn M. Brown & Lucas G. Hill. (2022) Opioid harm reduction: A scoping review of physician and system-level gaps in knowledge, education, and practice. Substance Abuse 43:1, pages 972-987.
Read now
Jonathan L. Robbins, Kathryn Bonuck, Philippe Thuillier, Catriona Buist & Patricia A. Carney. (2022) Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon . Substance Abuse 43:1, pages 825-833.
Read now
Maria Bolshakova, José Luis González, Tiana Thompson, Todd Schneberk, Steve Sussman, Jennifer B. Unger & Ricky N. Bluthenthal. (2022) A qualitative analysis of internal medicine residents’ experience with substance use disorder education and training: a pilot study. Journal of Addictive Diseases 0:0, pages 1-8.
Read now
Maria Robles, Leila Mortazavi, Julie Vannerson & Marianne S. Matthias. (2022) How a Medication for Opioid Use Disorder Curriculum Translates into Experiences and Internal Medicine Residents’ Understanding of Patients with Opioid Use Disorder. Teaching and Learning in Medicine 34:5, pages 514-521.
Read now
Sunny Lai, Erica Li, Alexis Silverio, Robin DeBates, Erin Lee Kelly & Lara Carson Weinstein. (2021) “It’s a place that gives me hope”: A qualitative evaluation of a buprenorphine-naloxone group visit program in an urban federally qualified health center. Substance Abuse 42:4, pages 858-864.
Read now
Sarah Sweeney, Kelly Coble, Elizabeth Connors, Kathleen Rebbert-Franklin, Christopher Welsh & Eric Weintraub. (2021) Program development and implementation outcomes of a statewide addiction consultation service: Maryland Addiction Consultation Service (MACS). Substance Abuse 42:4, pages 595-602.
Read now

Articles from other publishers (17)

Chinazo O. Cunningham & Joanna L. Starrels. (2023) Guideline Promoting Buprenorphine for Treatment of Chronic Pain: Transformative Yet Underdeveloped. Annals of Internal Medicine 176:3, pages 419-420.
Crossref
Emily Johnson, Maria Bolshakova, Aidan Vosooghi, Chun Nok Lam, Rebecca Trotzky-Sirr, Ricky Bluthenthal & Todd Schneberk. (2022) Effect of Didactic Training on Barriers and Biases to Treatment of Opioid Use Disorder: Meeting the Ongoing Needs of Patients with Opioid Use Disorder in the Emergency Department during the COVID-19 Pandemic. Healthcare 10:12, pages 2393.
Crossref
Caitlin E. Martin, Bhushan Thakkar, Lauren Cox, Elisabeth Johnson, Hendrée E. Jones & AnnaMarie Connolly. (2022) Beyond opioid prescribing: Evaluation of a substance use disorder curriculum for OBGYN residents. PLOS ONE 17:9, pages e0274563.
Crossref
Donna M. Windish, Jillian S. Catalanotti, Aimee Zaas, Michael Kisielewski & John P. Moriarty. (2021) Training in Safe Opioid Prescribing and Treatment of Opioid Use Disorder in Internal Medicine Residencies: a National Survey of Program Directors. Journal of General Internal Medicine 37:11, pages 2650-2660.
Crossref
Bryant Shuey, Dasom Lee, Israel Ugalde, Saif Borgan, Caroline Bresnan, Marvi Qureshi, Rahul Mhaskar & Asa Oxner. (2021) Evaluation of Resident Physicians’ Knowledge of and Attitudes Towards Prescribing Buprenorphine for Patients With Opioid Use Disorder. Journal of Addiction Medicine 15:3, pages 219-225.
Crossref
Danielle R. Fine, David Herzberg & Sarah E. Wakeman. (2020) Societal Biases, Institutional Discrimination, and Trends in Opioid Use in the USA. Journal of General Internal Medicine 36:3, pages 797-801.
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberJeffrey DeVido, Ellen Edens, Robert Werner & Elizabeth Howell. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
Delia Motavalli, Jessica L. Taylor, Ellen Childs, Pablo K. Valente, Peter Salhaney, Jennifer Olson, Dea L. Biancarelli, Alberto Edeza, Joel J. Earlywine, Brandon D. L. Marshall, Mari-Lynn Drainoni, Matthew J. Mimiaga, Katie B. Biello & Angela R. Bazzi. (2020) “Health Is on the Back Burner:” Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs. Journal of General Internal Medicine 36:1, pages 129-137.
Crossref
Kenneth L. Morford, Caroline G. Falker & Jeanette M. Tetrault. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings 161 171 .
Alene Kennedy-Hendricks, Colleen L. Barry, Elizabeth Stone, Marcus A. Bachhuber & Emma E. McGinty. (2020) Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians. Drug and Alcohol Dependence 216, pages 108217.
Crossref
Joseph H. Donroe, Elenore P. Bhatraju, Judith I. Tsui & E. Jennifer Edelman. (2020) Identification and Management of Opioid Use Disorder in Primary Care: an Update. Current Psychiatry Reports 22:5.
Crossref
Julienne K. Kirk, Tamela Yount, Charlotte T. Boyd, Lisa Cassidy-Vu, Aubry N. Koehler & John G. Spangler. (2020) Launching a Medication-Assisted Treatment in an Outpatient Office-Based Practice. Journal of Primary Care & Community Health 11, pages 215013272094072.
Crossref
Jarratt D. Pytell, Megan E. Buresh & Ryan Graddy. (2019) Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice. Addiction Science & Clinical Practice 14:1.
Crossref
Mim Ari, Michael Kisielewski, Nora Y. Osman, Karen Szauter, Clifford D. Packer & Amber T. Pincavage. (2019) Teaching Safe Opioid Prescribing During the Opioid Epidemic: Results of the 2018 Clerkship Directors in Internal Medicine Survey. Journal of General Internal Medicine 34:12, pages 2812-2817.
Crossref
Tamara BeethamBrendan SalonerSarah E. WakemanMarema GayeMichael L. Barnett. (2019) Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality. Annals of Internal Medicine 171:1, pages 1.
Crossref
Carlos Blanco & Nora D Volkow. (2019) Management of opioid use disorder in the USA: present status and future directions. The Lancet 393:10182, pages 1760-1772.
Crossref
Nathaniel P. Morris & Brandon S. Bentzley. (2018) Requiring Buprenorphine Waivers for Psychiatry Residents. Academic Psychiatry 43:1, pages 131-134.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.